US Patent Issued to Neurelis on Jan. 13 for "Administration of benzodiazepine compositions" (American, Belgian Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,400, issued on Jan. 13, was assigned to Neurelis Inc. (San Diego).

"Administration of benzodiazepine compositions" was invented by Steve Cartt (Hillsborough, Calif.), David Medeiros (Sparks, Nev.), Garry Thomas Gwozdz (Jim Thorpe, Pa.), Andrew Loxley (Brussels) and Mark Mitchnick (East Hampton, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions."

The patent was filed on July 24, 2024, under Application No. 18/782,646.

*For further information, including images, charts and ...